Establishes pharmacist licensing exemption for certain dialysis-related drugs and devices.

This bill exempts drug manufacturers and distributors from needing a pharmacist license when distributing FDA-approved dialysis drugs and devices for home use by patients with end-stage renal disease. It requires these products to be delivered only with a physician's order, in original sealed packaging, directly to patients, their designees, or healthcare providers. Manufacturers must contract with a licensed pharmacist for weekly quality assurance checks on storage and distribution. The exemption applies solely to dialysis-specific products under strict conditions, not to general pharmaceutical distribution.